Ito Sho, Kobayashi Hironori, Ikenouchi Tadasuke, Yamamoto Hideyuki, Takeuchi Shunta, Ogawa Masahiro
Department of Education and Training Center, Handa City Hospital.
Department of Respiratory Medicine, Handa City Hospital.
Nihon Ronen Igakkai Zasshi. 2023;60(3):283-287. doi: 10.3143/geriatrics.60.283.
The development and exacerbation of autoimmune diseases following coronavirus disease 2019 (COVID-19) vaccination have been reported; however, there are few reports of autoimmune hemolytic anemia (AIHA). A 75-year-old woman was admitted to the emergency department 46 days after receiving her third dose of the mRNA-1273 COVID-19 vaccine because of fatigue and general weakness. Initial laboratory analyses revealed severe hemolytic anemia with positive direct and indirect Coombs test and elevation of serum indirect bilirubin and lactate dehydrogenase. The patient had no underlying disease after a close examination and was diagnosed with warm AIHA, which was thought to be associated with COVID-19 vaccination. The anemia improved daily after the administration of prednisolone. Clinicians should be aware of the possibility of AIHA being caused by COVID-19 vaccination, and monotherapy with prednisolone should be considered in cases of severe anemia.
已有报告称2019冠状病毒病(COVID-19)疫苗接种后会出现自身免疫性疾病的发生和加重;然而,关于自身免疫性溶血性贫血(AIHA)的报告却很少。一名75岁女性在接种第三剂mRNA-1273 COVID-19疫苗46天后因疲劳和全身无力入住急诊科。初始实验室分析显示严重溶血性贫血,直接和间接抗人球蛋白试验呈阳性,血清间接胆红素和乳酸脱氢酶升高。经过仔细检查,患者无基础疾病,被诊断为温抗体型自身免疫性溶血性贫血,认为与COVID-19疫苗接种有关。给予泼尼松龙后贫血症状每日改善。临床医生应意识到COVID-19疫苗接种可能导致AIHA,对于严重贫血病例应考虑使用泼尼松龙进行单一治疗。